Hansa Biopharma — Januar 2023
-
Kort video - Ambu ' Bavarian Nordic ' Hansa Biopharma ' Genmab ' Novo Nordisk ' Zealand Pharma ' Anavex
Helge Larsen gennemgår det sidste nye om virksomhederne inden for pharma og biotek ud fra den kvalificerede debat og chat på Proinvestor. https://www.proinvestor.com/boards/109502/
-
Hansa var lidt under salgspres/gevinsthjemtagning, men modsat 2022, så kom den tilbage og sluttede i plus.
sådan var det bestemt ikke sidste år. -
Så er Hansa under salgspres igen idag….denne gang går den vist ikke fri

-
Så kender vi mønstret igen
desværre -
Hansa kører sine egne veje….fin kursudvikling på en generel MEGET sur dag

Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind